What’s the current market cap for 908 Devices stock?

908 Devices (MASS) has a market cap of $324m as of June 18, 2026.

What is the P/E ratio for 908 Devices stock?

The price to earnings (P/E) ratio for 908 Devices (MASS) stock is 0 as of June 18, 2026.

Does 908 Devices stock pay dividends?

No, 908 Devices (MASS) stock does not pay dividends to its shareholders as of June 18, 2026.

When is the next 908 Devices dividend payment date?

908 Devices (MASS) stock does not pay dividends to its shareholders.

What is the beta indicator for 908 Devices?

908 Devices (MASS) has a beta rating of 0.56. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy 908 Devices stock | $MASS Share Price

About 908 Devices

908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.

Ticker

$MASS

Sector

Digital Hardware

Primary listing

NASDAQ

Employees

172

Headquarters

Burlington, United States

Website

908devices.com

908 Devices Metrics

BasicAdvanced

$324m

-

-$0.99

0.56

-

What the Analysts think about 908 Devices

Analyst ratings (Buy, Hold, Sell) for 908 Devices stock.

908 Devices Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

908 Devices Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

908 Devices News

AllArticlesVideos

908 Devices Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Business Wire·2 weeks ago

908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook

Business Wire·1 month ago

908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio

Business Wire·1 month ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.